Skip to content

Clinical trials

Phase 2/3 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2/3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20142
20183
20191
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed3
Terminated3
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University2
Peking Union Medical College Hospital2
Peking University People's Hospital2
Bristol-Myers Squibb1
Jinling Hospital, China1
M.D. Anderson Cancer Center1
Medical College of Wisconsin1
Ruilan Wang1
Shandong University1
Terumo BCTbio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia15
Sepsis2
Sjogren's Syndrome2
Anemia1
Blast Crisis1
Bone Marrow Failure Disorders1
Hematologic Diseases1
Hepatitis1
Hepatitis C1
Inflammation1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.